Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01521728 · ClinicalTrials.gov registry record · NA
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01521728: Completed NA study, sponsored by Johns Hopkins University.
NCT01521728 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01521728, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The first questions asked by patients with a new diagnosis of Amyotrophic Lateral Sclerosis (ALS) often include: "Does exercise help slow the progression of the disease?", "Is there any harm in exercising?", or "What type of exercise (endurance or resistance) is most appropriate?" At this time, however, there is a lack of answers for people who suffer from an illness that affects their strength above all else. Yet the beneficial effects of exercise in both healthy people as well as people with other diseases have been extensively studied and resulted in recommendations about the types of exercise that are beneficial. In this study the investigators will ask participants with ALS to exercise in one of three ways: weightlifting (resistance exercise), stationary bicycling (endurance exercise), and range of motion exercise (the current "standard of care" for ALS patients). The investigators will use several different types of tests to determine whether one type of exercise is tolerated better and is safer than another. The investigators will also collect information about how the body responds to exercise in ALS. This study will help in the development of a larger national study to understand how exercise can be combined with other treatments to potentially improve strength and alter the course of the disease.
Interventions
- OTHER Endurance Exercise
- OTHER Resistance Exercise
- OTHER Stretching/Range-of-Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01521728
The ClinicalTrials.gov registry entry for NCT01521728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Endurance Exercise is the first listed.
NCT01521728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01521728 about?
NCT01521728 is a clinical study titled "Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)". The first questions asked by patients with a new diagnosis of Amyotrophic Lateral Sclerosis (ALS) often include: "Does exercise help slow the progression of the disease?", "Is there any harm in exercising?", or "What type of exercise (endurance or resistance) is most appropriate?" At this time, howe...
What is the current status of trial NCT01521728?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-01. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01521728?
The interventions under investigation include: Endurance Exercise (OTHER), Resistance Exercise (OTHER), Stretching/Range-of-Motion (OTHER).
Who is sponsoring clinical trial NCT01521728?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.